MGPI (MGP Ingredients Inc)
Insider Trading Activity
Every open-market purchase and sale reported by MGPI officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-24 | Paul S. Lux | 10%+ Owner | Sell | — | — |
| 2026-08-06 | Julie Maria Francis | President & CEO | F | — | — |
| 2026-08-06 | Julie Maria Francis | President & CEO | F | — | — |
| 2026-07-02 | Martin Roper | Director | A | — | — |
| 2026-05-28 | Caroline Lux Kaplan | 10%+ Owner | Sell | — | — |
| 2026-05-15 | GERARDO I LOPEZ | Director | A | — | — |
| 2026-05-15 | Martin Roper | Director | A | — | — |
| 2026-05-15 | THOMAS A GERKE | Director | A | — | — |
| 2026-05-15 | Jennifer Elaine Lowry | Director | A | — | — |
| 2026-05-15 | Mercedes Romero | Director | A | — | — |
| 2026-05-15 | Todd B. Siwak | Director | A | — | — |
| 2026-05-15 | Lori L.S. Mingus | Director | A | — | — |
| 2026-05-01 | Julie Maria Francis | President & CEO | A | — | — |
| 2026-04-02 | Martin Roper | Director | A | — | — |
| 2026-03-06 | Julie Maria Francis | President & CEO | A | — | — |
| 2026-03-06 | Kathleen Susan Molamphy | Chief Legal and HR Officer | A | — | — |
| 2026-03-06 | Brandon Gall | CFO | A | — | — |
| 2026-02-25 | Kathleen Susan Molamphy | Chief Legal and HR Officer | A | — | — |
| 2026-02-25 | Julie Maria Francis | President & CEO | A | — | — |
| 2026-02-25 | Brandon Gall | CFO | A | — | — |
| 2026-02-20 | Brandon Gall | CFO | F | — | — |
| 2026-02-20 | Amel Pasagic | Chief Commercial Officer | F | — | — |
| 2026-02-20 | Erika Lapish | CHRO | F | — | — |
| 2026-02-18 | Erika Lapish | CHRO | F | — | — |
| 2026-02-18 | Amel Pasagic | Chief Commercial Officer | F | — | — |
| 2026-02-18 | Brandon Gall | CFO | F | — | — |
| 2026-01-02 | Martin Roper | Director | A | — | — |
| 2025-12-10 | Karen Seaberg | Director | Sell | — | — |
| 2025-11-20 | Caroline Lux Kaplan | 10%+ Owner | Sell | — | — |
| 2025-10-03 | Martin Roper | Director | A | — | — |
| 2025-08-21 | Karen Seaberg | Director | J | — | — |
| 2025-08-05 | Julie Maria Francis | President & CEO | A | — | — |
| 2025-07-03 | Martin Roper | Director | A | — | — |
| 2025-05-22 | THOMAS A GERKE | Director | A | — | — |
| 2025-05-22 | Martin Roper | Director | A | — | — |
| 2025-05-22 | GERARDO I LOPEZ | Director | A | — | — |
| 2025-05-22 | Todd B. Siwak | Director | A | — | — |
| 2025-05-22 | KEVIN RAUCKMAN | Director | A | — | — |
| 2025-05-22 | Jennifer Elaine Lowry | Director | A | — | — |
| 2025-05-15 | Donn S. Lux | Director | Sell | — | — |
| 2025-05-13 | Caroline Lux Kaplan | 10%+ Owner | Sell | — | — |
| 2025-05-08 | Martin Roper | Director | Buy | — | — |
| 2025-05-02 | Karen Seaberg | Director | Sell | — | — |
| 2025-05-02 | Lori L.S. Mingus | Director | Sell | — | — |
| 2025-04-16 | GERARDO I LOPEZ | Director | A | — | — |
| 2025-04-16 | Martin Roper | Director | A | — | — |
| 2025-04-03 | THOMAS A GERKE | Director | A | — | — |
| 2025-04-03 | Preet H. Michelson | Director | A | — | — |
| 2025-04-02 | Lori L.S. Mingus | Director | Sell | — | — |
| 2025-04-02 | Karen Seaberg | Director | Sell | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 2,438,264 | — |
| — | 10%+ Owner | 1,787,614 | — |
| — | 10%+ Owner | 1,764,600 | — |
| — | 10%+ Owner | 644,789 | — |
| — | 10%+ Owner | 593,458 | — |
| — | 10%+ Owner | 550,458 | — |
| — | 10%+ Owner | 470,958 | — |
| — | President and CEO | 121,808 | — |
| — | Director | 121,045 | — |
| — | Director | 114,279 | — |
| — | President and CEO | 110,670 | — |
| — | President & CEO | 107,836 | — |
| — | Director | 105,494 | — |
| — | Chairman and CEO | 97,170 | — |
| — | Director | 96,860 | — |
| — | Vice President | 94,897 | — |
| — | CFO | 87,278 | — |
| — | President & CEO | 83,782 | — |
| — | Vice President | 82,237 | — |
| — | Director | 77,832 | — |
| — | Director | 75,828 | — |
| — | Director | 70,386 | — |
| — | Vice President | 68,444 | — |
| — | Director | 63,238 | — |
| — | EVP Research, Devel. & Innovat | 61,984 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the MGPI quote page; the site-wide leaderboard is on the insider transactions hub.